PEG-Interferon alfa-2b plus Ribavirin-Behandlung bei chronischer Hepatitis C

被引：0
|
作者：
机构：
来源：
Monatsschrift Kinderheilkunde | 2005年 / 153卷 / 12期
关键词：
D O I：
10.1007/s00112-005-1265-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1192 / 1193
页数：1
相关论文
共 50 条
  • [41] Metastatic renal cell carcinoma treated with Peg-interferon alfa-2b
    Lyrdal, David
    Stierner, Ulrika
    Lundstam, Sven
    ACTA ONCOLOGICA, 2009, 48 (06) : 901 - 908
  • [42] Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
    Poynard, Thierry
    Colombo, Massimo
    Bruix, Jordi
    Schiff, Eugene
    Terg, Ruben
    Flamm, Steven
    Moreno-Otero, Ricardo
    Carrilho, Flair
    Schmidt, Warren
    Berg, Thomas
    McGarrity, Thomas
    Heathcote, E. Jenny
    Goncales, Fernando
    Diago, Moises
    Craxi, Antonio
    Silva, Marcelo
    Bedossa, Pierre
    Mukhopadhyay, Pabak
    Griffel, Louis
    Burroughs, Margaret
    Brass, Clifford
    Albrecht, Janice
    GASTROENTEROLOGY, 2009, 136 (05) : 1618 - 1628
  • [43] Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin
    Kraus, MR
    Schäfer, A
    Wissmann, S
    Reimer, P
    Scheurlen, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (01) : 90 - 100
  • [44] Interferon alfa-2b and ribavirin in patients with resistant chronic hepatitis C.
    Min, AD
    Jones, JL
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Esposito, S
    Geders, JM
    Tobias, H
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 192A - 192A
  • [45] Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients -: A randomized controlled trial
    Carrat, F
    Bani-Sadr, F
    Pol, S
    Rosenthal, E
    Lunel-Fabiani, F
    Benzekri, A
    Morand, P
    Goujard, C
    Pialoux, G
    Piroth, L
    Salmon-Céron, D
    Degott, C
    Cacoub, P
    Perronne, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (23): : 2839 - 2848
  • [46] Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment
    Milton W Taylor
    Takuma Tsukahara
    Jeanette N McClintick
    Howard J Edenberg
    Paul Kwo
    Journal of Translational Medicine, 6
  • [47] Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment
    Taylor, Milton W.
    Tsukahara, Takuma
    McClintick, Jeanette N.
    Edenberg, Howard J.
    Kwo, Paul
    JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
  • [48] Sustained virological response of Peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection genotype IV
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    LIVER INTERNATIONAL, 2006, 26 : 81 - 81
  • [49] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1808 - 1809
  • [50] Pegylated interferon alfa-2b (PEG-Intron) monotherapy is superior to interferon alfa-2b (Intron A) for the treatment of chronic hepatitis C
    Trepo, C
    Lindsay, K
    Niederau, C
    Shiffman, M
    Gordon, S
    Hoefs, J
    Schiff, E
    Marcellin, P
    Bacon, B
    Fang, J
    Garaud, J
    Albrecht, J
    JOURNAL OF HEPATOLOGY, 2000, 32 : 29 - 29
12345